A Dark Vector Cognition product

Item 6. Exhibits

4K characters. Original on sec.gov ·

Item 6. Exhibits

(a) ExhibitsDescription of ExhibitsFiled with this Form 10-QIncorporation by Reference
FormFiling DateExhibit No.
10.1*Charles River Laboratories International, Inc. 2026 Long-term Incentive Plan8-KMay 11, 202610.1
10.2*Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2026 Long-Term Incentive Plan - United StatesX
10.3*Charles River Laboratories International, Inc. Form of Performance Share Unit granted under the 2026 Long-Term Incentive Plan - United StatesX
31.1Rule 13a-14(a)/15d-14(a) Certification of Chief Executive OfficerX
31.2Rule 13a-14(a)/15d-14(a) Certification of Chief Financial OfficerX
32.1+Certification of the Principal Executive Officer and the Principal Financial Officer required by Rule 13a-14(a) of 15d-14(a) of the Exchange ActX
101.INSeXtensible Business Reporting Language (XBRL) Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL documentX
101.SCHXBRL Taxonomy Extension Schema DocumentX
101.CALXBRL Taxonomy Calculation Linkbase DocumentX
101.DEFXBRL Taxonomy Definition Linkbase DocumentX
101.LABXBRL Taxonomy Label Linkbase DocumentX
101.PREXBRL Taxonomy Presentation Linkbase DocumentX
* Management contract or compensatory plan, contract or arrangement
+ Furnished herein.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
August 5, 2026/s/ BIRGIT GIRSHICK
Birgit Girshick Chief Executive Officer
August 5, 2026/s/ GLENN COLEMAN
Glenn Coleman Corporate Executive Vice President and Chief Financial Officer

Previous: Item 5. Other Information